Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large growth in short interest in July. As of July 15th, there was short interest totaling 29,822 shares, a growth of 1,142.6% from the June 30th total of 2,400 shares. Based on an average trading volume of 1,023,946 shares, the days-to-cover ratio is currently 0.0 days.

Psykey Price Performance

Shares of CEOS remained flat at $0.01 during trading hours on Friday. Psykey has a fifty-two week low of $0.00 and a fifty-two week high of $0.01. The stock has a 50-day moving average price of $0.01.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.